Secukinumab Trial Targets Relapsed Polymyalgia Rheumatica

• by Kathryn Wighton

• July 31, 2026

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

• by Andrea Surnit

• July 6, 2026

• 3 min

CAR-based cellular therapy for refractory systemic lupus erythematosus: an overlap-controlled systematic review

• by Sheng-Guang Li, Ruohan Yu, Lina Zhang, Jing Zhang, Yadan Zou, Ji Li, Ting Long, Yanfeng Zhang, Jing Pan

• July 1, 2026

Systemic lupus erythematosus associated with paroxysmal nocturnal hemoglobinuria: a case report and literature review highlighting the clinical significance of small PNH clones

• by Xiaoyan Huang, Jing Huang, Ning Liu, Lijun Zhang

• June 26, 2026